Mukundan said, "China, U.S. and Western Europe are witnessing slight declines due to reduced demand for flat and container glass." He cautioned that tariff uncertainties will continue to weigh on ...

Robitussin was at the center of a class-action complaint over its “non-drowsy” cough and cold medicines. Screengrab from Calchi, et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC ...

The glass container manufacturer posted adjusted earnings of $0.40 per share for Q1 2025, surpassing analyst estimates of $0.23. Revenue came in at $1.6 billion, topping the consensus forecast of ...